# ADR-445: Stage 219 Scope Freeze

**Status:** Accepted  
**Date:** 2026-08-13  
**Related:** [ADR-444](ADR_444_STAGE219_OPEN.md), [STAGE_219_EXIT_CRITERIA.md](STAGE_219_EXIT_CRITERIA.md), [STAGE_219_FIDELITY.md](STAGE_219_FIDELITY.md), [CHANGE_IMPACT_MVP_UPDATE_2026-08-13.md](CHANGE_IMPACT_MVP_UPDATE_2026-08-13.md)

## Context

Stage 219 Tenant MVP Production Hypercare Remaining-Gate Index Fidelity delivered production hypercare remaining-gate hub (I1), blocker matrix (B1), Stage 67 / Stage 218 / Stage 217 pointers (P1), fidelity sync (D1), and exit (H219x). Prior Stage 218 remains frozen under ADR-443.

## Decision

1. **Stage 219 is frozen for new feature scope** (bugfixes / test hardening / doc corrections only).
2. **Do not open Stage 220** until CONTINUE/NEXT with a distinct outline is approved.
3. Deferred items in Stage 219 exit criteria remain deferred.
4. **Stage 1–218 freezes remain in force**.
5. Honesty flags stay false including `live_production_hypercare_claimed`, `production_hypercare_live_claimed`, `oncall_rota_live`, plus prior Stage 218 honesty flags.
6. Do **not** claim live hypercare Complete, live continuity Complete, go-live Complete, or certification Completes.

## Consequences

- Agents treat Stage 219 I1 / B1 / P1 / D1 / H219x as closed unless fixing a regression.
- Main `ci.yml` remains deploy-free (**Stage 18 C1**).

## Next stage

Stage 220 opened under **ADR-446** after CONTINUE/NEXT (Support SLA Boundary Remaining-Gate Index Fidelity) and is frozen under **ADR-447**. Stage 219 feature scope remains frozen.

**Amendment (2026-08-13):** Stage 220 runner-up outline was approved and opened (ADR-446); freeze ADR-447. Do not reopen Stage 219 scope.
